Return to content in this issue

 

Omalizumab in the treatment of Hyper-IgE Syndrome - 2 case reports

Gomes N1, Miranda J2, Lopes S1, Carneiro-Leão L2, Torres Costa J2, Baudrier T1, Azevedo F1

1Dermatovenereology Department, Centro Hospitalar Universitário de São João, Porto
2Allergy and Clinical Immunology Department, Centro Hospitalar Universitário de São João, Porto

J Investig Allergol Clin Immunol 2020; Vol. 30(3)
doi: 10.18176/jiaci.0469

Key words: DOCK 8, Eczema, Hyper-IgE Syndrome, Omalizumab, STAT 3